🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the feasibility and safety of autologous transplantation of CD34+T...
Status
Completed
Location
Stanford University School of Medicine
Start Date
1996-09
Trial ID
NCT00186680
Treatments Being Tested
SCOT is a clinical research study designed for people with severe forms of ...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2005-06
Trial ID
NCT00114530
Treatments Being Tested
To evaluate the toxicity and tolerability of this tandem autologous/allogen...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2009-05
Trial ID
NCT00899847
Treatments Being Tested
Acute myeloid leukemia with t(8;21) /AML1-ETO-positive (AE AML) is a hetero...
Status
Completed
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02936089
This is a standard of care treatment guideline for high risk or relapsed so...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-10-20
Trial ID
NCT01505569
To evaluate the role of high dose chemotherapy with autologous hematopoieti...
Status
Completed
Location
Stanford University School of Medicine
Start Date
1998-03
Trial ID
NCT00186251
Treatments Being Tested
To evaluate the role of high dose therapy and autologous hematopoietic cell...
Status
Completed
Location
Stanford University School of Medicine
Start Date
1998-04
Trial ID
NCT00186407
Treatments Being Tested
To evaluate the role of purging the hematopoietic cell graft on outcomes fo...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2003-10
Trial ID
NCT00186355
Treatments Being Tested